Atlanta Braves Holdings, Inc. (BATRA) insider sells 3,830 Series C shares

Rhea-AI Filing Summary

Atlanta Braves Holdings, Inc. reported that its EVP, CFO & Treasurer converted 7,660 restricted stock units into Series C Common Stock on December 11, 2025, at an exercise price of $0 per share. On December 12, 2025, the executive sold 3,830 Series C shares in an open-market transaction coded as a sale, at a weighted average price of $39.70.

The sale was carried out under a Rule 10b5-1 sales plan adopted on May 15, 2025 and was intended to cover tax withholding obligations tied to the RSU vesting. The price range for the sale was from $39.37 to $40.12. After these transactions, the executive directly held 79,460 Series C shares, and the remaining restricted stock units continue vesting in tranches, with the final portion scheduled to vest on December 11, 2026.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Jill L.

(Last) (First) (Middle)

C/O ATLANTA BRAVES HOLDINGS, INC.

755 BATTERY AVENUE SE

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Atlanta Braves Holdings, Inc. [ BATRK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CFO & Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Series C Common Stock	12/11/2025		M		7,660	A	$0(1)	83,290	D
Series C Common Stock	12/12/2025		S(2)		3,830	D	$39.7(3)	79,460	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units - BATRK	(4)	12/11/2025		M			7,660	(5)	(5)	Series C Common Stock	7,660	$0	7,661	D

Explanation of Responses:

1. Each restricted stock unit converted into one share of Series C Common Stock.

2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025 and was intended to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.

3. Reflects the weighted average sale price. The range of prices for such transaction is $39.37 to $40.12. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.

4. Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.

5. One-third of the restricted stock unit award vested on each of December 11, 2024 and 2025, and the remaining restricted stock units vest on December 11, 2026.

	/s/ Kerry T. Wenzel, Attorney-in-Fact	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Atlanta Braves Holdings, Inc. (BATRA) report?

The company reported that its EVP, CFO & Treasurer converted 7,660 restricted stock units into Series C Common Stock on December 11, 2025, then sold 3,830 Series C shares on December 12, 2025 in an open-market sale.

How many Atlanta Braves Holdings shares does the executive own after the transaction?

Following the reported transactions, the executive directly beneficially owned 79,460 shares of Atlanta Braves Holdings, Inc. Series C Common Stock.

At what price were the Atlanta Braves Holdings shares sold?

The 3,830 Series C shares were sold at a weighted average price of $39.70 per share, within a price range of $39.37 to $40.12.

Was the Atlanta Braves Holdings insider sale made under a Rule 10b5-1 plan?

Yes. The sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 15, 2025, and was intended to cover tax withholding obligations related to the RSU vesting and settlement.

How do the restricted stock units in this Atlanta Braves Holdings Form 4 vest?

According to the disclosure, one-third of the restricted stock unit award vested on each of December 11, 2024 and December 11, 2025, and the remaining restricted stock units are scheduled to vest on December 11, 2026.

What type of securities are involved in this Atlanta Braves Holdings insider transaction?

The transaction involves Series C Common Stock (ticker BATRK) and related restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Series C Common Stock.